Cherry Hill, NJ, United States of America

Zhijia Zhang

This inventor holds 2 USPTO granted patents. Top assignee: Thomas Jefferson University. Active years: 2002-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhijia Zhang. Retrieved from https://idiyas.com/inventor/zhijia-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 95(Granted Patents)


Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhijia Zhang: Innovator in Cancer Research

Introduction

Zhijia Zhang is a prominent inventor based in Cherry Hill, NJ (US). He has made significant contributions to the field of cancer research through his innovative work. With a total of 2 patents, Zhang is recognized for his advancements in peptide cellular uptake and small molecule inhibitors.

Latest Patents

Zhang's latest patents focus on the enhancement of peptide cellular uptake. One of his notable inventions involves small molecule inhibitors of BCL-2 proteins. These inhibitors are designed to induce apoptosis in cells that are otherwise protected by BCL-2 mediated blockage. The compounds developed by Zhang are particularly useful in treating cancer, autoimmune disorders, and viral infections.

Career Highlights

Zhijia Zhang is affiliated with Thomas Jefferson University, where he conducts his research. His work has garnered attention for its potential impact on therapeutic strategies in oncology and related fields.

Collaborations

Zhang collaborates with esteemed colleagues, including Ziwei Huang and Jialun Wang, to further his research initiatives.

Conclusion

Zhijia Zhang's contributions to cancer research through his innovative patents highlight his role as a key inventor in the field. His work continues to pave the way for new treatment options and advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…